Cost-effectiveness of sunitinib as second line treatment in patients with metastatic renal cancer in Belgium

Authors
Publication date
1 January 2007
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Ghent University Academic Bibliography

    redirect
    oaioai:archive.ugent.be:8579799
    Last time updated on 17/03/2019